SIRS-Lab Declares Insolvency, Seeks Investor to Commercialize Sepsis Test
January 09, 2013
SIRS-Lab Declares Insolvency, Seeks Investor to Commercialize Sepsis Test
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- NIH Team Presents Findings from Fungi-focused Study of Skin Microbiome
May 22, 2013 / GenomeWeb Daily News - Royalties Drive up GeneNews Q1 Revenues Sharply
May 16, 2013 / GenomeWeb Daily News - Fluidigm Sees 2013 as 'Watershed Year' for Single-Cell Genomics, as C1 Sales Drive Q1 Revenues
May 7, 2013 / BioArray News - Analytik Jena Buys Assets of Insolvent MDx Firm SIRS-Lab
May 6, 2013 / GenomeWeb Daily News - Fluidigm Reports 33 Percent Spike in Q1 Revenues
May 2, 2013 / GenomeWeb Daily News